<DOC>
	<DOCNO>NCT02702908</DOCNO>
	<brief_summary>This study aim estimate incidence second primary malignancy well overall survival among metastasized prostate cancer ( mPC ) metastasize castrate-resistant prostate cancer ( mCRPC ) patient treat radium-223-dichloride .</brief_summary>
	<brief_title>Second Primary Cancers Patients With Castration Resistant Prostate Cancer</brief_title>
	<detailed_description>This study aim estimate incidence second primary malignancy well overall survival among mPC mCRPC patient treat radium-223-dichloride . The source data study German Pharmacoepidemiological Research Database ( GePaRD ) . A retrospective cohort study cover time period 2004 2013 conduct . The study population comprise CRPC patient develop bone metastasis . These patient follow occurrence second primary malignancy , end study , death due cause . As study serve historical control group single-arm observational study , incidence rate second primary malignancy obtain study compare standardized incidence ratio use result study reference .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>Members mPC cohort fulfill follow criterion : Valid information sex , age region residence A period least 12 month continuous insurance precede cohort entry Diagnosis PC ( ICD10 Code C61 ) study period ( 01Jan2004 31Dec2011 ) Diagnosis bone metastasis ( ICD10 Code C79.5 ) enrolment period ( 01Jan2005 31Dec2011 ) In addition criterion mPC cohort , member mCRPC additionally fulfill : One follow enrolment period time bone metastases Discontinuation initial chemical castration , change agent modality Androgen deprivation therapy ( ADT ) , start treatment advanced Prostate cancer ( PC ) primary ADT . Surgical castration initiation ADT treatment Treatment medication specific mCRPC . Patients exclude mPC mCRPC population meet one follow criterion : First PC diagnosis later 2 month diagnosis bone metastasis , Use radiopharmaceuticals bone metastasis ( e.g. , samarium , strontium , rhenium , radium )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>